Loading evaluation data…
Cells respond to DNA double-strand breaks by recruiting factors such as the DNA-damage mediator protein MDC1, the p53-binding protein 1 (53BP1), and the breast cancer susceptibility protein BRCA1 to sites of damaged DNA. Here, we reveal that the ubiquitin ligase RNF8 mediates ubiquitin conjugation and 53BP1 and BRCA1 focal accumulation at sites of DNA lesions. Moreover, we establish that MDC1 recruits RNF8 through phosphodependent interactions between the RNF8 forkhead-associated domain and motifs in MDC1 that are phosphorylated by the DNA-damage activated protein kinase ataxia telangiectasia mutated (ATM). We also show that depletion of the E2 enzyme UBC13 impairs 53BP1 recruitment to sites of damage, which suggests that it cooperates with RNF8. Finally, we reveal that RNF8 promotes the G2/M DNA damage checkpoint and resistance to ionizing radiation. These results demonstrate how the DNA-damage response is orchestrated by ATM-dependent phosphorylation of MDC1 and RNF8-mediated ubiquitination.
Strengths
Depletion, siRNA-resistant rescue, domain-specific mutants, phosphopeptide binding, live-cell imaging, and pharmacological ATM inhibition all converge on the same MDC1-to-RNF8-to-ubiquitin-to-effector pathway. This multi-pronged design makes the central causal model robust.
↳ Results, Figs. 2-3
siRNA-resistant murine RNF8 rescue distinguishes on-target from off-target RNAi effects, and FHA (R42A) versus RING (C403S) mutants cleanly separate the recruitment and catalytic functions of RNF8. These controls are exemplary for the era.
↳ Figs. 2D-F, 3A-C, S7
By identifying RNF8 as the upstream ligase organizing ubiquitin signaling at double-strand breaks, the paper supplies the enzymatic step that concurrent RAP80 work lacked and links it to clinically relevant BRCA1 and 53BP1 recruitment. The advance is positioned at a critical node of an active field.
↳ Abstract; Introduction; Fig. 4E
Limitations
Conclusions rest largely on representative images and percentage-of-cells-with-foci data, with sample sizes and statistical tests not consistently reported in the main text. This was common for 2007 cell biology but limits quantitative assessment by current standards.
↳ Results, Figs. 1-4
The paper shows that ubiquitin foci depend on RNF8 but does not identify the direct substrate(s), leaving a mechanistic gap between RNF8 catalytic activity and 53BP1/BRCA1 recruitment. This limitation is acknowledged only implicitly.
↳ Results; Discussion
Findings are established in U2OS and HeLa cells with mouse-complementation and DT40 corroboration but without primary-cell or in vivo validation. This keeps the work at a preclinical, mechanistic stage and bounds its near-term translational reach.
↳ Results; ref 26
The assessment is anchored by a tightly controlled experimental design in which depletion, siRNA-resistant rescue, and domain-specific FHA and RING mutants converge with phosphopeptide binding and live-cell imaging on a single mechanistic model (Figs. 2-3). The contribution scores highly because the work supplies the upstream ligase linking ATM-phosphorylated MDC1 to ubiquitin-dependent 53BP1 and BRCA1 recruitment, a step left open by concurrent RAP80 studies. Counterweighing this are sparse formal statistics and sample sizes in the main text and the unidentified direct ubiquitinated substrate, which hold the craft and contribution scores below the airtight ceiling. On impact, the functional endpoints in Fig. 4C-D (clonogenic survival and the G2/M checkpoint) supply genuine enabling biology, but the confinement to transformed cell lines without in vivo validation is the dominant constraint on near-term translation.
Exemplary4.4/5.0
The paper fills a specific mechanistic gap by identifying RNF8 as the E3 ligase that links ATM-phosphorylated MDC1 to ubiquitin-dependent recruitment of 53BP1 and BRCA1 at double-strand breaks, providing the upstream enzymatic step that concurrent RAP80 work lacked. Claims are proportionate to convergent loss-of-function, rescue, peptide-binding, and functional evidence.
we identify RNF8 as the prime ubiquitin ligase for poly-ubiquitination at DSB sites
The design layers orthogonal approaches—siRNA/esiRNA depletion, siRNA-resistant murine RNF8 rescue, FHA (R42A) and RING (C403S) domain mutants, phosphopeptide pulldowns, live-cell imaging, and pharmacological ATM inhibition—into a coherent specificity-controlled dissection. The principal limitations are minimal formal statistical reporting and sample sizes in the main text and the unidentified direct ubiquitinated substrate.
Introduction of RNAi-resistant murine RNF8 into cells transfected with RNF8 siRNA restored 53BP1 focus formation
The argument flows logically from MDC1 TQXF phosphorylation through RNF8 recruitment and ubiquitin-chain formation to downstream effector recruitment and functional consequences, with the Fig. 4E model summarizing the pathway and hedged language where direct binding could not be shown. The connection between the independent RNAi screen and the MDC1 TQXF narrative could be more explicitly bridged.
we were unable to detect such interactions (Fig. 3B), suggesting that MDC1-dependent 53BP1 IRIF formation is likely mediated by an additional factor
The study situates itself substantively against concurrent RAP80 work (refs 13-16), the MDC1/gammaH2AX literature (refs 7-12), and explicitly addresses the complicating observation that 53BP1 foci form in ATM-deficient cells by adding pharmacological ATM-inhibition data. It lacks a formal limitations section and leaves the unidentified direct substrate only implicitly flagged, both genre-appropriate for a 2007 letter.
although 53BP1 IRIF formation can occur in ATM-deficient AT cells (18, 19), we found that pharmacological inhibition of ATM impaired 53BP1 focus formation
Watch-outs4 of 4 checks
The mechanistic narrative is internally consistent across abstract, main text, and figures, with convergent orthogonal assays supporting the same model and negative results reported transparently.
No ethics, conflict-of-interest, or data-availability statements are present, but all are era-appropriate omissions for a 2007 basic cell-biology study using standard cell lines and commercial reagents, and none are material to interpretation.
Flags: 0 declared / 5 total
All 27 cited references resolved to real publications via PubMed, Crossref, or OpenAlex.
An expression of concern was published on 2024-12-05. See notice.
Sources: Retraction Watch ✓PubPeer (coming soon)
Medium3.7/5.0
The work addresses a central biomedical problem—organization of repair at DNA double-strand breaks—with an actionable pathway relevant to cancer biology and radiation response, but its immediate users are basic and translational researchers rather than direct clinical decision-makers. Application relevance is real but indirect.
RNF8 promotes the G2/M DNA damage checkpoint and resistance to ionizing radiation
Findings are mechanistic proof-of-concept established in cultured cells but anchored by functional endpoints—clonogenic survival and the G2/M checkpoint—that constitute strong enabling biology for subsequent therapeutic or biomarker work. Deployment remains several steps away.
RNF8 depletion caused IR hyper-sensitivity in clonogenic cell-survival assays
The pathway is demonstrated in human U2OS and HeLa cells and corroborated by mouse-complementation (murine RNF8 rescues human depletion) and DT40 genetic data (ref 26), supporting generality across a conserved pathway. Evidence is confined to transformed cell lines without primary-cell or in vivo validation.
Introduction of RNAi-resistant murine RNF8 into cells transfected with RNF8 siRNA restored 53BP1 focus formation
The paper sits at a critical node of an active, cumulative DDR literature, identifying the upstream ligase whose characterization enabled subsequent work on the histone-ubiquitination cascade and related effectors. No reviewer cited a material weakness in its trajectory for downstream build-out.
RNF8 then triggers the formation of poly-ubiquitin chains that promote recruitment of the RAP80-BRCA1 complex and 53BP1 to DSB sites
Nabu’s assessment, alongside the field’s view.
Evaluation Metadata
AI-powered, human-governed. Something look off? Contact us to request a review.